An in vivo study of cell-mediated immunity in human warts. Preliminary results.
Purified human papilloma virus (HPV) was used to study cell-mediated immunity (CMI) in patients with warts and in controls by means of the intradermal test (IDT). IDT was positive in 75% of patients with past history of warts, in 56% of patients presenting with warts, but in only 7% of controls. Immunofluorescent antibody levels were initially low and increased after injection of HPV antigen in all groups.
D000914:Antibodies, Viral / Q000032:analysis; D006801:Humans; D007106:Immune Sera; D007111:Immunity, Cellular; D027383:Papillomaviridae / Q000276:immunology; D012871:Skin Diseases / Q000276:immunology*; D014860:Warts / Q000276:immunology*
D000914:Antibodies, Viral; D007106:Immune Sera